texas oncology more breakthroughs. more victories
Some of our cancer centers are experiencing issues.  View More Important Notifications x

Texas Oncology Opens New Cancer Center in the Alliance Corridor

FORT WORTH, Texas (July 5, 2022) – Texas Oncology recently opened a new 22,300-square- foot cancer care center in the Alliance Corridor. Located at 9750 Hillwood Parkway, at Alliance Town Center, the new Texas Oncology–Keller provides medical oncology, hematology, and infusion treatments, all in one location. Texas Breast Specialists–Keller, which provides breast surgery services, is also on site.

“This new cancer center allows us to bring advanced cancer care to more patients in the growing Alliance Corridor and Keller region,” said Steven Paulson, M.D., president and chairman of the board, Texas Oncology. “Texas Oncology provides leading-edge cancer care where our patients live and work, and this new cancer care facility confirms our ongoing commitment to provide innovative, comprehensive, and individualized care for patients across Texas.”

The new cancer center is a significant expansion for Texas Oncology–Keller, doubling the number of infusion chairs available to patients. In late August, the center will offer radiation oncology services with a Varian Truebeam linear accelerator for radiation treatment.

“As people and businesses continue to move to the Alliance Corridor and Keller region, access to comprehensive cancer care becomes increasingly important,” said Henrik Illum, M.D., medical oncologist, Texas Oncology–Keller. “With a range of specialties and services, and an integrated team of physicians, nurses, and support staff, Texas Oncology–Keller expects to care for more than 100 patients per day.”

Hillwood and Meridian served as the real estate developers of the project. Corgan and E4H served as the architects and DPR Construction was the general contractor.

About Texas Oncology

Texas Oncology is an independent private practice with more than 500 physicians and 220 locations across the state. Meeting the oncology needs of Texans for more than 35 years, the practice includes Texas Center for Proton Therapy, Texas Breast Specialists, Texas Oncology Surgical Specialists, Texas Urology Specialists, and Texas Center for Interventional Surgery. As a lead participant in US Oncology Research, Texas Oncology played a role in the development of more than 100 FDA-approved therapies. For more information, visit www.TexasOncology.com.